Clinical Trial Update: Comparison of the Efficacy of Pirfenidone and Nintedanipine in Pulmonary Fibrosis

View source ↗

Summary

A completed clinical trial directly comparing pirfenidone and nintedanib for efficacy in idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Esbriet (pirfenidone)
• OFEV (Nintedanib)

Snippet

Sponsor: Karadeniz Technical University | Conditions: Idiopathic Pulmonary Fibrosis (IPF) | Status: COMPLETED